肾旁及胸腹主动脉瘤紧急开窗分支腔内修复术后结局
单中心回顾性评估32例不适合开放手术的肾旁或胸腹主动脉瘤患者接受紧急或急诊开窗分支腔内修复的结局。技术成功97%,30天死亡6%,30天主要不良事件16例(50%),1年总生存70%±8%,无主动脉相关死亡94%±3,无二次干预83%±7。作者认为对解剖合适的选择性患者该治疗可行且可能安全。
要点
- 32例肾旁或胸腹主动脉瘤患者接受紧急或急诊开窗分支腔内修复,技术成功97%。
- 30天死亡2例(6%),主要不良事件16例(50%),包括3例轻微卒中。
- 1年总生存70%±8%,无主动脉相关死亡94%±3,无二次干预83%±7。
核心结论
- 对解剖合适的肾旁及胸腹主动脉瘤选择性患者,紧急开窗分支腔内修复是可行且可能安全的治疗,早期死亡率和脊髓并发症发生率低。
- 需要长期随访评估修复耐久性和器械相关并发症。
研究设计与样本
- 单中心回顾性研究,评估症状性、快速增大或破裂的肾旁及胸腹主动脉瘤患者接受开窗分支腔内修复的结局。
- 共32例患者(23例男性,平均年龄74±9岁),在12年期间接受医师改良覆膜支架或公司制造器械治疗。
- 14例因包裹性破裂行急诊修复,18例因症状性、真菌性或快速增大动脉瘤行紧急修复。
- 动脉瘤分类为肾旁10例、胸腹主动脉瘤22例(IV型9例,I-III型13例)。
- 23例(72%)使用医师改良覆膜支架,8例(26%)使用公司制造器械。
主要发现
- 技术成功率为97%,共使用67个开窗(68%)、29个定向分支(29%)和2个宽双扇贝(2%)纳入98条肾-肠系膜动脉。
- 30天死亡率为6%,1例出院后死亡原因不明,另1例死于肠系膜缺血。
- 30天主要不良事件发生于16例(50%),包括3例轻微卒中、1例短暂性轻瘫、1例心力衰竭和6例早期重返手术室。
- 平均随访24±22个月,1年总生存为70%±8%,无主动脉相关死亡为94%±3,无二次干预为83%±7。
临床怎么用
- 作者认为,对解剖合适的肾旁及胸腹主动脉瘤选择性患者,紧急开窗分支腔内修复是可行且可能安全的治疗。
- 作者指出需要长期随访评估修复耐久性和器械相关并发症。
局限性
- 原文报告为回顾性、单中心评估。
- 原文指出需要长期随访评估修复耐久性和器械相关并发症。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To evaluate outcomes following urgent or emergent fenestrated-branched endovascular aortic repair (F-BEVAR) for pararenal (PRA) and thoracoabdominal aortic aneurysms (TAAA) in patients who are considered high-risk for open repair. METHODS: A retrospective, single institution evaluation of outcomes following F-BEVAR of symptomatic, rapidly enlarging, or ruptured PRA or TAAA treated with physician modified endograft (PMEG) and company manufactured devices (CMD). Outcomes were technical success, 30-day morbidity and mortality, and 1 year aortic related outcomes. RESULTS: Thirty-two patients (23 male, mean age, 74 ± 9 years) underwent F-BEVAR using PMEG or CMD over a 12-year period. Fourteen patients underwent emergent repair for contained rupture and 18 patients underwent urgent repair for symptomatic, mycotic, or rapidly growing aneurysms. Aneurysm classification was PRA in 10 patients and TAAA in 22 (9 extent IV and 13 extent I-III). Twenty-three patients (72%) were repaired with PMEG and 8 patients (26%) with CMD. Technical success was 97% with a total of 98 renal-mesenteric arteries incorporated using 67 fenestrations (68%), 29 directional branches (29%), and 2 double-wide scallops (2%). A 30-day mortality was 6%, with 1 patient expiring from unclear causes after hospital discharge and the other from mesenteric ischemia. Mortality and major adverse events MAEs otherwise occurred in 16 patients (50%), including minor stroke in 3 patients, transient paraparesis and heart failure in 1 patient each, and early return to the operating room in 6 patients. Mean follow-up was 24 ± 22 months. At 1-year, overall survival, freedom from aortic-related mortality and freedom from secondary intervention were 70% ± 8%, 94% ± 3 and 83% ± 7, respectively. CONCLUSIONS: Urgent F-BEVAR of selected patients with PRA and TAAA is a feasible and potentially safe treatment in patients with suitable anatomy, with low rates of early mortality and spinal cord complications. Long-term follow-up is needed to assess the durability of repair and device-related complications.
引用
- Biggs JH, Tenorio ER, DeMartino RR, et al. Outcomes Following Urgent Fenestrated-Branched Endovascular Repair for Pararenal and Thoracoabdominal Aortic Aneurysms. Ann Vasc Surg. 2022. PMID: 35595206. doi:10.1016/j.avsg.2022.05.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。